| Literature DB >> 33959803 |
Euan N Paterson1, Charlotte E Neville1, Sara M Wallace1, Jayne V Woodside1, Frank Kee1, Ian S Young1, Sharon Cruise1, Bernadette McGuinness1, Alexander P Maxwell1, Gareth J McKay2.
Abstract
BACKGROUND: Dietary-based primary prevention guidelines for chronic kidney disease (CKD) treatment are lacking due to limited evidence. Single nutrient intake studies do not account for complex dietary interactions. We assessed associations between dietary patterns and renal function in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA).Entities:
Keywords: Dietary pattern; EGFR; NICOLA; Nutrition; Renal function
Mesh:
Year: 2021 PMID: 33959803 PMCID: PMC8437851 DOI: 10.1007/s00394-021-02579-z
Source DB: PubMed Journal: Eur J Nutr ISSN: 1436-6207 Impact factor: 5.614
Population characteristics
| Variable | Mean (SD) |
|---|---|
| Age (years) | 64.4 (9.3) |
| Male, | 1224 (47.3) |
| Body fat (%) | 43.8 (6.4) |
| Waist circumference (cm) | 95.1 (13.9) |
| Mean BMI (kg/m2) | 28.7 (5.1) |
| BMI < 25 kg/m2 | 589 (23) |
| 25 ≥ BMI < 30 kg/m2 | 1139 (44) |
| BMI ≥ 30 kg/m2 | 862 (23) |
| Systolic blood pressure (mmHg) | 133 (18) |
| Diastolic blood pressure (mmHg) | 81 (11) |
| LDL (mmol/L) | 3.34 (1.10) |
| HDL (mmol/L) | 1.61 (0.44) |
| eGFR CKD-EPI SCr SCys (ml/min/1.73m2) | 73.5 (16.3) |
| CKD stages 1–2 | 2082 (82) |
| CKD stage 3 | 350 (14) |
| CKD stage 4–5 | 117 (4) |
| Diabetes mellitus, | 219 (8.5) |
| Hypertensive, | 1038 (40) |
| Using lipid modifying agents, | 869 (34) |
| Using antihypertensive drugs, | 59 (2.3) |
| Using drugs for diabetes control, | 149 (5.8) |
| Education level: | |
| Primary or less, | 375 (15) |
| Secondary, | 1125 (44) |
| Tertiary, | 1089 (41) |
| Smoking | |
| Never, | 1389 (54) |
| Ex, | 966 (37) |
| Current, | 234 (9) |
| Alcohol consumption | |
| Current, | 1785 (69) |
| Ex, | 374 (14) |
| Never, | 430 (17) |
Hypertension was defined as a systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg or if use of antihypertensive medication was self-reported. Medication use was defined according to the Anatomical Therapeutic Chemical (ATC) Classification System that classifies the active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties
SD Standard deviation, BMI body mass index, LDL Low-density lipoprotein cholesterol, HDL High-density lipoprotein cholesterol, eGFR estimated glomerular filtration rate (CKD-EPI SCr and SCys), CKD chronic kidney disease
Dietary patterns and factor loadings identified using principal components analysis
| Dietary pattern 1 | Dietary pattern 2 | Dietary pattern 3 | |||
|---|---|---|---|---|---|
| Food group | Factor loading | Food group | Factor loading | Food group | Factor loading |
| Vegetables | 0.698 | Processed meat | 0.578 | Coffee | 0.455 |
| Wholegrains | 0.561 | White bread | 0.516 | Wine | 0.436 |
| Fruit | 0.554 | Confectionary | 0.507 | Beer | 0.415 |
| Oily fish | 0.478 | Fried potatoes | 0.492 | Other alcohol | 0.402 |
| Dairy e.g. cream, yogurt, cheese | 0.474 | Red meat | 0.474 | Refined grains | 0.272 |
| White fish | 0.471 | Added sugar i.e. sugar added to tea, coffee, cereal | 0.379 | Crisps | 0.252 |
| Soups, sauces, condiments | 0.450 | Other soft drinks | 0.376 | Lasagne/pizza | 0.251 |
| Refined grains | 0.424 | Crisps | 0.359 | Butter | − 0.210 |
| Higher fibre breads | 0.377 | Butter | 0.313 | Margarine | − 0.266 |
| Poultry | 0.349 | Soups, sauces, condiments | 0.313 | Confectionary | − 0.268 |
| Eggs | 0.323 | Lasagne/pizza | 0.291 | Higher fibre breads | − 0.357 |
| Nuts | 0.304 | Margarine | 0.278 | Cereals | − 0.384 |
| Tofu | 0.233 | Natural potatoes | 0.265 | Natural potatoes | − 0.425 |
| Lasagne / pizza | 0.231 | Other alcohol | 0.212 | Tea | − 0.530 |
| Cereals | 0.202 | ||||
Mean renal function (unadjusted) and mean difference in renal function (unadjusted and adjusted) by quintiles of dietary pattern adherence
| Least adherent | Low adherence | Middle adherence | High adherence | Highest adherence | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean eGFR (SD) ml/min/1.73m2 | 71.3 (16.6) | 71.6 (16.7) | 73.5 (16.0) | 75.1 (16.1) | 76.0 (15.3) | |||||
| Mean difference in eGFR (ml/min/1.73m2) from reference category (95% CI): | ||||||||||
| Unadjusted | − 4.7 (− 6.7, − 2.8) | < 0.001 | − 4.4 (− 6.4, − 2.4) | < 0.001 | − 2.5 (− 4.5, − 0.6) | 0.01 | − 0.9 (− 2.9, 1.1) | 0.37 | Ref | < 0.001 |
| Adjusted | − 3.4 (− 5.0, − 1.7) | < 0.001 | − 2.7 (− 4.3, − 1.1) | 0.001 | − 2.5 (− 4.1, − 0.9) | 0.002 | − 0.9 (− 2.5, 0.7) | 0.28 | Ref | < 0.001 |
| Dietary pattern 2 | ||||||||||
| Mean eGFR (SD) ml/min/1.73m2 | 76.2 (16.2) | 72.7 (16.4) | 72.3 (16.2) | 72.6 (16.3) | 73.8 (16.3) | |||||
| Mean difference in eGFR (ml/min/1.73m2) from reference category (95% CI): | ||||||||||
| Unadjusted | 2.3 (0.4, 4.3) | 0.02 | − 1.2 (− 3.1, 0.8) | 0.25 | − 1.6 (− 3.5, 0.4) | 0.12 | − 1.2 (− 3.2, 0.8) | 0.24 | Ref | 0.04 |
| Adjusted | 1.9 (0.2, 3.5) | 0.03 | − 0.3 (− 1.9, 1.3) | 0.71 | − 0.7 (− 2.3, 0.9) | 0.38 | − 1.2 (− 2.8, 0.4) | 0.15 | Ref | 0.02 |
| Dietary pattern 3 | ||||||||||
| Mean eGFR (SD) ml/min/1.73m2 | 70.0 (15.9) | 70.4 (16.5) | 73.9 (16.5) | 75.3 (15.7) | 78.1 (15.3) | |||||
| Mean difference in eGFR (ml/min/1.73m2) from reference category (95% CI): | ||||||||||
| Unadjusted | − 8.0 (− 10.0, − 6.1) | < 0.001 | − 7.7 (− 9.6, − 5.8) | < 0.001 | − 4.2 (− 6.1, − 2.2) | < 0.001 | − 2.8 (− 4.8, − 0.8) | 0.005 | Ref | < 0.001 |
| Adjusted | − 1.8 (− 3.5, − 0.01) | 0.05 | − 3.2 (− 4.8, − 1.5) | < 0.001 | − 1.5 (− 3.1, 0.2) | 0.08 | − 0.4 (− 2.0, 1.3) | 0.65 | Ref | 0.001 |
eGFR estimated glomerular filtration rate (CKD-EPI SCr and SCys), CI Confidence interval. Mean eGFR values are unadjusted. Adjusted models included age, sex, diabetes status, systolic blood pressure, smoking status, alcohol consumption, waist circumference, high-density lipoprotein, low-density lipoprotein, lipid-modifying agent use, antihypertensive and diabetes drug use, multiple-deprivation score, and education level